Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 7788 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 779
  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    InDex Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    InDex Pharmaceuticals AB (InDex) is an immunology focused biopharmaceutical company. It focuses on development of two products from its proprietary technology platform. Its product includes Kappaproct, which is in Phase III clinical trials for the treatment of refractory ulcerative colitis. The company’s product DIMS 9054 is development
    Englisch | Zukunftsanalyse | SKU: 331863
  3. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014

    GlobalData
    75 pages
    GlobalData's clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014" provides data on the Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysmal Subarachnoid Hemorrhage (SAH). It
    Englisch | Zukunftsanalyse | SKU: 403059
  4. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Respiratory Depression Global Clinical Trials Review, H2, 2014

    GlobalData
    59 pages
    GlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, H2, 2014" provides data on the Respiratory Depression clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respiratory Depression. It includes an overview of the trial numbers and their re
    Englisch | Zukunftsanalyse | SKU: 987672191
  5. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Klebsiella Pneumoniae Infections - Pipeline Review, H2 2015

    Global Markets Direct
    107 pages
    Global Markets Direct’s, ‘Klebsiella Pneumoniae Infections - Pipeline Review, H2 2015’, provides an overview of the Klebsiella Pneumoniae Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Klebsiella Pneumoniae Infections, complete with comparative analysis at variou
    Englisch | Marktstudie | SKU: 987689379
  6. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Global Markets Direct
    543 pages
    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 987688191
  7. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014

    GlobalData
    91 pages
    GlobalData's clinical trial report, “Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014" provides data on the Papillary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Papillary Thyroid Cancer. It includes an overview of the trial numbers and th
    Englisch | Marktstudie | SKU: 402056
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    inVentiv Health, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    27 pages
    inVentiv Health, Inc (inVentiv Health) is one of the leading providers of value-added services to the pharmaceutical, life sciences and healthcare industries. The company provides a wide range of activities that are related to clinical development, commercialization and consulting activities to its customers. Its client base includes over
    Englisch | Zukunftsanalyse | SKU: 270730
  9. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    VasGene Therapeutics, Inc. – Product Pipeline Review – 2012

    Global Markets Direct
    21 pages
    Introduction Global Market Direct’s pharmaceuticals report, “VasGene Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the VasGene Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued an
    Englisch | Report | SKU: 318099
  10. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis

    GlobalData
    68 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of pr
    Englisch | Report | SKU: 329193
  11. $1,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Zensun (Shanghai) Sci & Tech Co., Ltd. - Product Pipeline Review - 2014

    Global Markets Direct
    28 pages
    Global Markets Direct’s, ‘Zensun (Shanghai) Sci & Tech Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the Zensun (Shanghai) Sci & Tech Co., Ltd.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Zensun (Shanghai)
    Englisch | Zukunftsanalyse | SKU: 987671837

Items 1 to 10 of 7788 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 779